Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
Fernándo González‐Ortiz, Michael Turton, Przemysław R. Kac, et al.
Brain (2022) Vol. 146, Iss. 3, pp. 1152-1165
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Harald Hampel, Yan Hu, Jeffrey L. Cummings, et al.
Neuron (2023) Vol. 111, Iss. 18, pp. 2781-2799
Open Access | Times Cited: 118
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Fernándo González‐Ortiz, Przemysław R. Kac, Wagner S. Brum, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 111
A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease
Fernándo González‐Ortiz, Pâmela C.L. Ferreira, Armand González‐Escalante, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 1239-1249
Open Access | Times Cited: 44
Alzheimer's disease pathophysiology in the Retina
Bhakta Prasad Gaire, Yosef Koronyo, Dieu‐Trang Fuchs, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101273-101273
Open Access | Times Cited: 25
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Burak Arslan, Henrik Zetterberg, Nicholas J. Ashton
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1063-1069
Open Access | Times Cited: 24
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Qiuyang Zheng, Xin Wang
Protein & Cell (2024)
Open Access | Times Cited: 24
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Fernándo González‐Ortiz, Bjørn‐Eivind Kirsebom, José Contador, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
Xuemei Zeng, Yijun Chen, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease
Tohidul Islam, Emily Hill, Eric E. Abrahamson, et al.
Nature Medicine (2025)
Open Access | Times Cited: 5
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis
Samir Abu‐Rumeileh, Leila Motlagh Scholle, Alexander Mensch, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults
Lei Yu, Patricia A. Boyle, Shorena Janelidze, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 1, pp. 1-11
Open Access | Times Cited: 33
Plasma biomarkers for neurodegenerative disorders: ready for prime time?
Wasiu Gbolahan Balogun, Henrik Zetterberg, Kaj Blennow, et al.
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 2, pp. 112-118
Open Access | Times Cited: 32
Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives
Saqer Al Abdullah, Lubna Najm, Liane Ladouceur, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 37
Open Access | Times Cited: 27
Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases
Yongkyu Park, Nirajan KC, Alysta Paneque, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6295-6295
Open Access | Times Cited: 15
Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway
Sneha Narasimhan, David M. Holtzman, Liana G. Apostolova, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 7, pp. 1236-1252
Closed Access | Times Cited: 14
Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease
Michael Schöll, Inge M.W. Verberk, Marta del Campo, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 10, pp. 100630-100630
Open Access | Times Cited: 13
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 12
Alzheimer’s disease biomarkers and their current use in clinical research and practice
T. Hunter, Luís E. Santos, Fernanda Tovar‐Moll, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 12
Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia
Vincent Bouteloup, Isabelle Pellegrin, Bruno Dubois, et al.
Neurology (2024) Vol. 102, Iss. 8
Open Access | Times Cited: 10
Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood
Jianman Wang, Xing Lü, Yao He
Biosensors (2025) Vol. 15, Iss. 2, pp. 85-85
Open Access | Times Cited: 1
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study
Nicholas J. Ashton, Ashvini Keshavan, Wagner S. Brum, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 1
Trajectories of blood-based protein biomarkers in chronic traumatic brain injury
Amelia J. Hicks, Jay Plourde, Enna Selmanovic, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top